Get started
Author

A.A. Zukiwski

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.
1994 · A Sella, R Kilbourn, et al. · Journal of Clinical Oncology · 122
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
1994 · J L Murray, J E Cunningham, et al. · Journal of Clinical Oncology · 119
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.
1995 · C J Logothetis, L D Finn, et al. · Journal of Clinical Oncology · 73
Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.
1991 · L M Lamki, A U Buzdar, et al. · PubMed · 42
Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
1990 · L M Lamki, A A Zukiwski, et al. · PubMed · 36
Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases.
1990 · G M Mavligit, A A Zukiwski, et al. · Journal of Clinical Oncology · 34
Trans-ungual Delivery of AR-12, a Novel Antifungal Drug
2017 · Avadhesh Singh Kushwaha, P. Sharma, et al. · AAPS PharmSciTech · 19
Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial.
1991 · R Gonzalez, P Salem, et al. · PubMed · 16
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.
1994 · C J Logothetis, E Hossan, et al. · PubMed · 14
Interlenkin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M. D. Anderson Cancer Center
1989 · D.R. Parkinson, M. Talpaz, et al. · Cancer Treatment Reviews · 9
Rifampin-resistant meningococcal infection in a patient given rifampin chemoprophylaxis
1988 · Peter Berkey, Kenneth Rolston, et al. · American Journal of Infection Control · 9
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies.
1991 · K Itoh, C M Balch, et al. · PubMed · 4
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status
2017 · A. Jayaram, K. Nowakowska, et al. · Annals of Oncology · 3
473 Evaluation of the Relation Specific PR Biomarkers to the Preclinical Activity of Onapristone
2012 · G. Serin, E. Gilles, et al. · European Journal of Cancer · 1
431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers
2014 · F. Lokiec, J. Bonneterre, et al. · European Journal of Cancer
Abstract P6-05-13: Tumor and cellular distribution of activated forms of ER and PR in breast cancers
2013 · J Bonneterre, J Bosq, et al. · Cancer Research
Salvage Therapy in Metastatic Non-Seminomatous Germ Cell Tumour at the University of Texas M.D. Anderson Cancer Center
1994 · R.J. Amato, L. Finn, et al. · Elsevier eBooks
Works count: 17
Citation count: 501
H-index: 9
I10-index: 9
Year
Topic
Type